171 related articles for article (PubMed ID: 20189212)
1. Low- and high-risk human papillomavirus E7 proteins regulate p130 differently.
Barrow-Laing L; Chen W; Roman A
Virology; 2010 May; 400(2):233-9. PubMed ID: 20189212
[TBL] [Abstract][Full Text] [Related]
2. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S
Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395
[TBL] [Abstract][Full Text] [Related]
3. Nonconserved lysine residues attenuate the biological function of the low-risk human papillomavirus E7 protein.
Genovese NJ; Broker TR; Chow LT
J Virol; 2011 Jun; 85(11):5546-54. PubMed ID: 21411531
[TBL] [Abstract][Full Text] [Related]
4. Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells.
Nor Rashid N; Yusof R; Watson RJ
J Gen Virol; 2011 Nov; 92(Pt 11):2620-2627. PubMed ID: 21813705
[TBL] [Abstract][Full Text] [Related]
5. The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.
Zhang B; Chen W; Roman A
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):437-42. PubMed ID: 16381817
[TBL] [Abstract][Full Text] [Related]
6. Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes.
Genovese NJ; Banerjee NS; Broker TR; Chow LT
J Virol; 2008 May; 82(10):4862-73. PubMed ID: 18321970
[TBL] [Abstract][Full Text] [Related]
7. The human papillomavirus type 58 E7 oncoprotein modulates cell cycle regulatory proteins and abrogates cell cycle checkpoints.
Zhang W; Li J; Kanginakudru S; Zhao W; Yu X; Chen JJ
Virology; 2010 Feb; 397(1):139-44. PubMed ID: 19945133
[TBL] [Abstract][Full Text] [Related]
8. A postulated role of p130 in telomere maintenance by human papillomavirus oncoprotein E7.
Zhang W; Tian Y; Chen JJ; Zhao W; Yu X
Med Hypotheses; 2012 Aug; 79(2):178-80. PubMed ID: 22595804
[TBL] [Abstract][Full Text] [Related]
9. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.
Harden ME; Prasad N; Griffiths A; Munger K
mBio; 2017 Jan; 8(1):. PubMed ID: 28049151
[TBL] [Abstract][Full Text] [Related]
10. Pocket proteins suppress head and neck cancer.
Shin MK; Pitot HC; Lambert PF
Cancer Res; 2012 Mar; 72(5):1280-9. PubMed ID: 22237625
[TBL] [Abstract][Full Text] [Related]
11. Disruption of pocket protein dream complexes by E7 proteins of different types of human papillomaviruses.
Nor Rashid N; Yusof R; Watson RJ
Acta Virol; 2013; 57(4):447-51. PubMed ID: 24294959
[TBL] [Abstract][Full Text] [Related]
12. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
Armstrong DJ; Roman A
Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
[TBL] [Abstract][Full Text] [Related]
13. A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.
Hatterschide J; Brantly AC; Grace M; Munger K; White EA
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581101
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
15. Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes.
Banerjee NS; Genovese NJ; Noya F; Chien WM; Broker TR; Chow LT
J Virol; 2006 Jul; 80(13):6517-24. PubMed ID: 16775338
[TBL] [Abstract][Full Text] [Related]
16. HPV 16E7 and 48E7 proteins use different mechanisms to target p130 to overcome cell cycle block.
Nor Rashid N; Yong ZL; Yusof R; Watson RJ
Virol J; 2016 Jan; 13():2. PubMed ID: 26728921
[TBL] [Abstract][Full Text] [Related]
17. In-vivo analysis of hpv e7 protein association with prb, p107 and p130.
Hu T; Ferril S; Snider A; Barbosa M
Int J Oncol; 1995 Jan; 6(1):167-74. PubMed ID: 21556519
[TBL] [Abstract][Full Text] [Related]
18. Role of WDHD1 in Human Papillomavirus-Mediated Oncogenesis Identified by Transcriptional Profiling of E7-Expressing Cells.
Zhou Y; Zhang Q; Gao G; Zhang X; Liu Y; Yuan S; Wang X; Chen JJ
J Virol; 2016 Jul; 90(13):6071-6084. PubMed ID: 27099318
[TBL] [Abstract][Full Text] [Related]
19. PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis.
Hatterschide J; Bohidar AE; Grace M; Nulton TJ; Kim HW; Windle B; Morgan IM; Munger K; White EA
Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7033-7042. PubMed ID: 30894485
[TBL] [Abstract][Full Text] [Related]
20. HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner.
Rabachini T; Boccardo E; Andrade R; Perez KR; Nonogaki S; Cuccovia IM; Villa LL
BMC Cancer; 2018 Apr; 18(1):485. PubMed ID: 29703186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
